Concepedia

Jennifer L. Konopka‐Anstadt

JL

Statistics

Publications

21

Citations

1.2K

H-Index

19

Active since

2013

Affiliations

Centers for Disease Control and Prevention(Current)

Gates Foundation

Program for Appropriate Technology in Health

University of California, San Francisco

PT Bio Farma (Indonesia)

Jennifer L. Konopka‐Anstadt is an author at Centers for Disease Control and Prevention specializing in medicine, viral pathogenesis, and immunology.

ORCID

Top concepts

Publications per year

2013–2023

21

Publications

21

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Pierre Van Damme, Ilse De Coster, Ananda S Bandyopadhyay et al. · The Lancet · 2019 · 143 citations · Full text

Pan-viral serology implicates enteroviruses in acute flaccid myelitis

Ryan Schubert, Isobel A. Hawes, Prashanth Ramachandran et al. · Nature Medicine · 2019 · 127 citations · Full text

, , +4

Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization

Jennifer L. Konopka‐Anstadt, Raymond P. Campagnoli, Annelet Vincent et al. · npj Vaccines · 2020 · 94 citations · Full text

Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis

Nischay Mishra, Terry Fei Fan Ng, Rachel L. Marine et al. · mBio · 2019 · 91 citations · Full text

The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus

Jennifer L. Konopka‐Anstadt, Bernardo A. Mainou, Danica M. Sutherland et al. · Cell Host & Microbe · 2014 · 88 citations · Full text

, , +4

Rows per page

1–5 of 21